2016
Antipsychotic-Induced Weight Gain in First-Episode Psychosis Patients: A Meta-Analysis of Differential Effects of Antipsychotic Medications
Tek C, Kucukgoncu S, Guloksuz S, Woods SW, Srihari VH, Annamalai A. Antipsychotic-Induced Weight Gain in First-Episode Psychosis Patients: A Meta-Analysis of Differential Effects of Antipsychotic Medications. FOCUS The Journal Of Lifelong Learning In Psychiatry 2016, 14: 370-377. PMID: 31997958, PMCID: PMC6988756, DOI: 10.1176/appi.focus.140308.Peer-Reviewed Original Research
2011
P03-79 - How do european psychiatry trainees prescribe when treating depression, and what influences decision-making? (Survey of the European Federation of Psychiatric Trainees Research Group)
Jauhar S, Guloksuz S, Marques J, Nawka A, Roventa C, Psaras R, Andlauer O, Lydall G, De Vriendt N, Mendonca L, Van Zanten J, Dumiterscu I, Nwachukwu I, Riese F, Group E. P03-79 - How do european psychiatry trainees prescribe when treating depression, and what influences decision-making? (Survey of the European Federation of Psychiatric Trainees Research Group). European Psychiatry 2011, 26: 1248. DOI: 10.1016/s0924-9338(11)72953-4.Peer-Reviewed Original ResearchSide effect profileClinical practiceChoice of antidepressantSevere depressive episodeAntidepressant medicationDepressive episodeTreatment choiceResponse rateAntidepressantsSimilar antidepressantsSubsequent guidelinesPatientsEvidence baseMinimum response rateGuideline suggestionsRecent evidenceMedicationsEuropean traineesPsychiatry traineesEfficacyLittle evidenceSample sizeTraineesFactorsRecent literature
2010
P03-343 - Treatment choice in psychiatry? How would European trainees treat psychosis for their patients and themselves, and what influences decision-making?
Jauhar S, Guloksuz S, Marques J, Bendix M, Lydall G, Andlauer O, Gerber S, Roventa C, Van Zanten J, De Vriendt N, Nawka A, Nwachukw I, Dobrzynska E, Mufic A, Nazaraliev A, Dumitrescu I, Mendonca L, Riese F, Group E. P03-343 - Treatment choice in psychiatry? How would European trainees treat psychosis for their patients and themselves, and what influences decision-making? European Psychiatry 2010, 25: 958. DOI: 10.1016/s0924-9338(10)70949-4.Peer-Reviewed Original ResearchFirst-line therapySide effect profileTreatment choiceClinical practicePsychiatric clinical practiceEuropean traineesCATIE trialAntipsychotic medicationAntipsychoticsResponse ratePatientsEvidence baseMinimum response ratePsychosisRecent evidenceClozapineTherapyEfficacySample sizeTraineesPsychiatryMedicationsPrescribingFactorsRespondersThe treatment of bipolar disorder during pregnancy and the postpartum period.
Gülöksüz S, Akdeniz F, Ince B, Oral E. The treatment of bipolar disorder during pregnancy and the postpartum period. Turkish Journal Of Psychiatry 2010, 21: 155-66. PMID: 20514566, DOI: 10.5080/u6131.Peer-Reviewed Original ResearchConceptsPostpartum periodBipolar disorderPsychotropic medicationsBD patientsOnset of BDRisk of relapseRisk-benefit decisionsNeonatal toxicityPregnant patientsAdverse eventsObstetrical outcomesFetal exposureSafety profileBreast milkPharmacological treatmentPrevent recurrenceTreatment optionsMedication effectsPsychotropic agentsReproductive yearsNeurobehavioral developmentRecurrence increasesPregnancyPatientsMedications